JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pha... ( JMAR Technol...)

JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pharma Market

Date:1/28/2009

JMAR Technologies, Inc. (OTCBB: JMAR), a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced that JMAR's microbial contamination detection expert John A. Adams, Ph.D. will be speaking at the 2009 International Foundation Process Analytical Chemistry (IFPAC) annual meeting on Wednesday, January 28, 2009, in Baltimore, Maryland.

San Diego (Vocus) January 28, 2009 -- JMAR Technologies, Inc. (OTCBB: JMAR), a leading innovator in the development and commercialization of sensing systems for the detection of chemical, biological, radiological, nuclear and explosive (CBRNE) materials, today announced that JMAR's microbial contamination detection expert John A. Adams, Ph.D. will be speaking at the 2009 International Foundation Process Analytical Chemistry (IFPAC) annual meeting on Wednesday, January 28, 2009, in Baltimore, Maryland.

The IFPAC annual meeting, combining industry leaders and research institutions with officials from the U.S. Food and Drug Administration (FDA), focuses on the latest developments in emerging technologies: Process Analytical Technology (PAT), Quality by Design (QbD), and Real-Time Analytics. Dr. Adams was invited by Pfizer to present "Automated Real-Time On-Line Measurement of Bacteria in Water using Multi-Angle Light Scattering (MALS) Techniques." JMAR successfully uses MALS technology in its award-winning, laser-based BioSentry® product, the only commercialized, E
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3 4
Related biology technology :

1. Amylin Pharmaceuticals Appoints Vincent Mihalik Senior Vice President, Sales and Marketing and Chief Commercial Officer
2. Dr. Steven L. Zelenkofske Joins Regado Biosciences as Senior Vice President, Clinical and Medical Affairs and Chief Medical Officer
3. PAREXEL Appoints Josephine Hoppe to Chief Information Officer
4. Cequent Names Ted Hibben Chief Business Officer
5. Agendia Appoints New Chief Financial Officer
6. Kiadis Pharma Appoints Dr. Maarten Egeler, MD PhD as Chief Medical Officer
7. Epitomics Appoints Dr. Zhiqiang An as Chief Scientific Officer
8. Algeta Appoints Andrew Kay as President and Chief Executive Officer
9. Interface Biologics secures $5mm financing and appoints Thomas P. Reeves President and Chief Executive Officer
10. AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
11. Histogen Welcomes Dr. Hyma Gollamudi as Chief Business Officer

Post Your Comments:

JMAR Technologies' Chief Scientist Invited by Pfizer Inc. to Speak at IFPAC -- BioSentry Makes Strides in Pha...( JMAR Technol...)